16 Oct Prestige Secures Sr. Physician, For Rare Disease Client – Clinical Research
Prestige Scientific announces the successful completion of a Sr. Medical Director for Clinical Research and Development for our client, an early stage biotech developing novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases based upon complement immunotherapy.
Milford MA. – September 2018- Prestige Scientific, an executive search firm, announced its successful completion of a Sr. Medical Director, Clinical R&D Search reporting to the Chief Medical Officer. This physician will be responsible for overseeing the development strategy and activities for one of the company’s core clinical programs. This executive will lead the clinical development plans for multiple high-priority assets in nephropathies.
Strategic Leadership Objectives:
- Build and drive clinical development plans for multiple early, mid and late stage assets
- Represent high value program to Senior Management, Board of Directors and KOL’s
- Advance assets to major regulatory submissions and commercialization
Client: Publicly-held, clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system.
About Prestige Scientific: Prestige Scientific provides our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own while overcoming challenges and adhering to critical timelines. This systematic approach has proven to decrease our client’s time-to-fill while increasing hiring accuracy. On average our executive searches are completed in 59 days, with the eventual hire presented to the client by the 9th day of the search, with a success rate of 99.7%. Prestige Scientific team members specialize by Practice Area and are deeply anchored in each discipline.